Author | Lightnews

Tisento Therapeutics @tisentotx.bsky.social · 7h

Findings from our #MELAS interview study were recently published in the Journal of Patient-Reported Outcomes. The study highlighted the symptoms & impacts most important to patients and informed our Phase 2b PRIZM study. #MitochondrialDisease #PRO #Biosky www.tisentotx.com/news/tisento...

Tisento Therapeutics @tisentotx.bsky.social · 6d

Meet Roberto and Anna! Married for 30+ years, they support one another through Roberto’s journey with MELAS. We’re honored to support #MitoCon in telling stories of those affected by this #RareDisease. See their story (Italian w/ English subtitles): youtu.be/mwkczr_QDxg #Biosky

MELAS | Teaser testimonianza di Anna e Roberto

youtu.be

Tisento Therapeutics @tisentotx.bsky.social · 11d

Meet Morena! She’s a mom and a retired nurse, loves deeply connecting with people, and lives with #MELAS. We’re honored to support #MitoCon in telling stories of those affected by this #RareDisease. See Morena’s story (Italian w/ English subtitles): youtu.be/bFciPejLNPg #Biosky

MELAS | Teaser testimonianza di Morena

YouTube video by Mitocon Odv

youtu.be

1

Tisento Therapeutics @tisentotx.bsky.social · Sep 25

Last call for our PRIZM clinical study in #MELAS! We’re expecting to complete enrollment in the next few weeks. Those who are interested in participating at one of our sites around the world can find out more by talking to their doctor. #ClinicalResearch #MitochondrialDisease www.tisentotx.com/prizm

Tisento Therapeutics @tisentotx.bsky.social · Sep 22

It was so inspiring to see so many people around the world sharing stories and raising awareness about #MitochondrialDisease during #WorldMitoWeek2025. We’re honored to be part of such a wonderful global community. #DecodeTheMitoPuzzle #LightUpForMito #BioSky

London Mitochondrial Centre @londonmito.bsky.social · Sep 19

It's World Mitochondrial Disease Awareness Week 💚

Since we couldn't #LightUpForMito this year the team's looking lit in green to raise awareness instead!

Read more here: www.thelilyfoundation.org.uk/charity/get-...

#mitoaware #mitochondrialdisease #worldmitoweek2025 @lilyfoundation.bsky.social

1

Tisento Therapeutics @tisentotx.bsky.social · Sep 20

To us, #LightUpForMito is personal. While monuments and landmarks around the world are lit up in green, we’re lighting up our homes, our pets, and ourselves. We stand with the #MitochondrialDisease community! #WorldMitoWeek2025 #DecodeThePuzzle #Biosky

1

Tisento Therapeutics @tisentotx.bsky.social · Sep 20

Tonight, landmarks, buildings & monuments around the world will light up in GREEN to shine a light on #MitochondrialDiseases. This display raises visibility, sparks conversations & shows solidarity with the mito community. #LightUpForMito #WorldMitoWeek2025 #Biosky mitopatients.org/light-up-for...

Tisento Therapeutics @tisentotx.bsky.social · Sep 19

Your voice matters for those affected by #MitochondrialDisease! International Mito Patients (IMP) has practical tips and useful resources for getting involved during #WorldMitoWeek2025 and beyond! #DecodeTheMitoPuzzle #Biosky mitopatients.org/mito-week/

Tisento Therapeutics @tisentotx.bsky.social · Sep 18

#MELAS can affect multiple organ systems and frequently causes a range of severe and burdensome symptoms. We are working on what could be the first treatment for this devastating disease through our PRIZM MELAS study. #WorldMitoWeek2025 #MitochondrialDisease #DecodeTheMitoPuzzle #Biosky

Tisento Therapeutics @tisentotx.bsky.social · Sep 17

Collaboration among researchers, clinicians & patients translates science into real-world impact for those with #MitochondrialDisease. We’re proud to be part of this network with our PRIZM #MELAS clinical study. #WorldMitoWeek2025 #DecodeTheMitoPuzzle #Biosky www.tisentotx.com/prizm

Tisento Therapeutics @tisentotx.bsky.social · Sep 16

Mitochondria are known as “the powerhouse of the cell,” generating ~90% of the energy our bodies need and playing a critical role in many different bodily systems and organs. #MitochondrialDiseases have broad and debilitating consequences. #WorldMitoWeek2025 #DecodeTheMitoPuzzle #Biosky

Tisento Therapeutics @tisentotx.bsky.social · Sep 15

#WorldMitoWeek2025 starts today! This advocacy week is intended to raise awareness about #MitochondrialDiseases with a goal of improving the lives of people affected by these diseases. Join us in supporting this global community! #MitochondrialDisease #DecodeTheMitoPuzzle #Biosky

1

Tisento Therapeutics @tisentotx.bsky.social · Sep 9

Next week is #WorldMitoWeek2025. We love the theme, #DecodeTheMitoPuzzle, focused on connecting science to lived experiences with #MitochondrialDisease. Our PRIZM #MELAS study is rooted in this approach & is screening now but not for much longer! #WeHearYou #Biosky www.tisentotx.com/prizm

Tisento Therapeutics @tisentotx.bsky.social · Aug 25

We’re on a mission to deliver medicines that address what matters most for people with #MitochondrialDiseases, beginning with MELAS and our Phase 2b PRIZM study. Learn more: www.tisentotx.com/prizm #ClinicalResearch #NowEnrolling #RareDisease

Tisento Therapeutics @tisentotx.bsky.social · Aug 21

Interested in participating in our Phase 2b PRIZM study for adults with MELAS? We expect to complete enrollment soon, but we are still looking for a few more participants. Reach out right away! www.tisentotx.com/prizm #ClinicalResearch #MitochondrialDisease #RareDisease #Biosky

Tisento Therapeutics @tisentotx.bsky.social · Aug 20

Our #MELAS open-label extension study has officially started! The first participant is now enrolled after completing treatment in our global Phase 2b PRIZM study. PRIZM is actively enrolling and expected to complete screening in the next months. #Biosky www.tisentotx.com/news/first-p...

Tisento Therapeutics @tisentotx.bsky.social · Aug 7

We’re so proud of Hannah Milne, who is training for the #ChicagoMarathon and fundraising for the United Mitochondrial Disease Foundation! Hannah is the daughter of our chief operating officer Todd Milne and is proud to run this race on behalf of #TeamTisento. #Biosky give.umdf.org/fundraiser/6...

Tisento Therapeutics @tisentotx.bsky.social · Jul 31

#DidYouKnow: International Mito Patients (IMP) is a network of 18 patient organizations, spanning 3 continents, that support people with #MitochondrialDiseases globally. IMP also supports people living in countries without a national mito organization. #Biosky mitopatients.org/members/

1

Tisento Therapeutics @tisentotx.bsky.social · Jul 23

Living with #MitochondrialDisease? Beat the heat this summer with these useful tips from #MitoAction! Be sure to consult with your doctor as well. #Biosky www.mitoaction.org/day-to-day-w...

Tisento Therapeutics @tisentotx.bsky.social · Jun 30

#ICYMI: Tune into the #MitoAction “Energy in Action” podcast to hear about our PRIZM Phase 2 study in MELAS, how patient interviews helped shape the study, and our commitment to listening to patients. #MitochondrialDisease #RareDisease #ClinicalResearch #Biosky bit.ly/3I7Hp3V

1 2

Tisento Therapeutics @tisentotx.bsky.social · Jun 19

At #MitoMed? Stop by the Research Pavilion to check out the mitoARCH (Mitochondrial All-Comers Research on Cognitive Health) study! We’re hoping to unearth new insights about the impact of cognitive health in #MitochondrialDisease. #Biosky @UMDF umdfconference.org/clinical-res...

2

Tisento Therapeutics @tisentotx.bsky.social · Jun 18

#MitoMed 2025 starts today! We’re looking forward to discussing the latest developments in #MitochondrialMedicine and connecting with researchers, healthcare providers, patients, and families from around the world. Stop by our booth! #Biosky

Tisento Therapeutics @tisentotx.bsky.social · Jun 17

We’re excited to share that our investigational, once-daily, oral medicine has been granted Fast Track designation by @fda.gov‬ for the treatment of MELAS! #MitochondrialDisease #RareDisease #ClinicalDevelopment #Biosky www.tisentotx.com/news/tisento...

Tisento Therapeutics @tisentotx.bsky.social · Jun 12

Thanks to #MitoAction for having us on the “Energy in Action” podcast! Tune in to learn about our PRIZM MELAS study, our lead compound, and our commitment to listening to patients. #MitochondrialDisease #RareDisease #ClinicalResearch #Biosky energy-in-action-by-mitoaction.castos.com/episodes/how...

Tisento Therapeutics @tisentotx.bsky.social · Jun 2

Attending #MitoMed 2025 and interested in contributing to #ClinicalResearch in #MitochondrialMedicine? Consider participating in the mitoARCH study, which is designed to better understand the impact of primary #MitochondrialDisease (PMD) on cognition. umdfconference.org/clinical-res...